Gianna Musettini

HER2 Overexpression as a Poor Prognostic Determinant in Resected Biliary Tract Cancer

Caterina Vivaldi, Lorenzo Fornaro, Clara Ugolini et al. · The Oncologist · 2020 · 50 citations · Full text

First‐line treatment with FOLFOXIRI for advanced pancreatic cancer in clinical practice: Patients' outcome and analysis of prognostic factors

Caterina Vivaldi, Chiara Caparello, Gianna Musettini et al. · International Journal of Cancer · 2016 · 46 citations · Full text

Surgical Oncology, First‐line Treatment, Gastroenterology +17

Total neoadjuvant approach with FOLFOXIRI plus bevacizumab followed by chemoradiotherapy plus bevacizumab in locally advanced rectal cancer: the TRUST trial

Gianluca Masi, Caterina Vivaldi, Lorenzo Fornaro et al. · European Journal of Cancer · 2019 · 36 citations · Full text

Surgical Oncology, Radiation Therapy, Gastrointestinal Oncology +8

Impact of a supportive care service for cancer outpatients: management and reduction of hospitalizations. Preliminary results of an integrated model of care

Andrea Antonuzzo, Enrico Vasile, Andrea Sbrana et al. · Supportive Care in Cancer · 2016 · 23 citations

Nursing, Family Medicine, Integrated Care +14

EGFR and AKT1 overexpression are mutually exclusive and associated with a poor survival in resected gastric adenocarcinomas

Iacopo Petrini, Monica Lencioni, Enrico Vasile et al. · Cancer Biomarkers · 2017 · 19 citations